Market Tracker

05/24 5:16pm ET

Galena Biopharma Inc (NASDAQ:GALE)

1.74
Delayed Data
As of 4:00pm ET
 +0.07 / +4.19%
Today’s Change
0.59
Today|||52-Week Range
2.39
+18.37%
Year-to-Date
No recent news for Galena Biopharma Inc.

Today’s Trading

Previous close1.67
Today’s open1.75
Day’s range1.66 - 1.77
Volume3,709,510
Average volume (3 months)1,930,877
Market cap$303.7M
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-23.32%
Earnings growth (this year)+32.68%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book20.01

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+0.13+1.28%
RGLSRegulus Therapeutics...+0.15+2.63%
TLGTTeligent Inc+0.24+4.28%
KPTIKaryopharm Therapeut...+0.73+8.39%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$59.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
San Ramon, California

Forecasts